A KDM4B/JMJD2B inhibitor 1 mg


≥98% pure A KDM4B/JMJD2B inhibitor 1 mg



NCGC00244536 is an inhibitor of KDM4B/JMJD2B histone lysine demethylase (IC50 = ~10 nM).1 It is selective for KDM4B/JMJD2B over KDM5A/JARID1 and lysine-specific demethylase 1 (LSD1) but does inhibit KDM4A/JMJD2A, KDM4C/JMJD2C, and KDM4D/JMJD2D at 10 μM. NCGC00244536 inhibits the growth of PC3, DU145, LNCaP, VCaP, and C4-2 prostate cancer cells (IC50s = <1 μM for all). It reduces androgen receptor levels and trimethylation of histone 3 lysine 9 (H3K9) in isolated human solid prostate tumors. NCGC00244536 (20 mg/kg, s.c.) reduces tumor volume in a PC3 mouse xenograft model.WARNING This product is not for human or veterinary use.


There are no reviews yet.

Be the first to review “A KDM4B/JMJD2B inhibitor 1 mg”

Your email address will not be published.

Got something to discuss?


Add to cart